Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

• Status: Completed
• Trial end date: 2009-03-01

Summary

Objective: To determine the response to rapid hormonal cycling in patients with non-castrate prostate cancer.

• Phase: Phase 2

Details

• Lead Sponsor: Memorial Sloan Kettering Cancer Center
• Treatments: Bicalutamide; Estrogens; Goserelin; Ketoconazole; Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate